Acorda Therapeutics, Inc.
ACORDelisted Apr 25, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001008848
Acorda Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Jun 23, 2023; 17 institutions reported holding it in 13F filings for Q1 2024, worth $2.13M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Acorda Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −1 vs. Q2 2021
- Shares held
- 3.20M
- −582.8K (−15.4%) vs. Q2 2021
- Total value
- $14.7M
- −$3.33M (−18.4%) vs. Q2 2021
- New holders
- 5
- 9 more added
- Sold out
- 6
- 11 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 2 | $8.00K |
| Q1 2024 | 17 | $2.13M |
| Q4 2023 | 15 | $2.33M |
| Q3 2023 | 16 | $2.30M |
| Q2 2023 | 15 | $1.94M |
| Q1 2023 | 30 | $3.71M |
| Q4 2022 | 36 | $4.09M |
| Q3 2022 | 36 | $1.91M |
| Q2 2022 | 35 | $3.08M |
| Q1 2022 | 34 | $5.42M |
| Q4 2021 | 34 | $9.48M |
| Q3 2021 | 36 | $14.7M |
| Q2 2021 | 37 | $18.1M |
| Q1 2021 | 37 | $18.0M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Acorda Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 724,718 | $3.33M | 0.00% | +10,600+1.5% | Added |
| Point72 Asset Management, L.P. | 468,166 | $2.15M | 0.01% | −420,733−47.3% | Reduced |
| Canyon Capital Advisors LLC | 392,904 | $1.81M | 0.06% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 382,404 | $1.76M | 0.01% | +2,482+0.7% | Added |
| Vanguard Group Inc | 341,545 | $1.57M | 0.00% | +1,064+0.3% | Added |
| BlackRock Inc. | 161,939 | $744.0K | 0.00% | −5,310−3.2% | Reduced |
| Bridgeway Capital Management, LLC | 140,590 | $647.0K | 0.01% | +39,000+38.4% | Added |
| Federated Hermes, Inc. | 98,485 | $453.0K | 0.00% | −6,331−6.0% | Reduced |
| Invesco Ltd. | 82,911 | $381.0K | 0.00% | +2,904+3.6% | Added |
| Geode Capital Management, LLC | 46,721 | $214.0K | 0.00% | −26,841−36.5% | Reduced |
| Dimensional Fund Advisors LP | 41,856 | $193.0K | 0.00% | −35,552−45.9% | Reduced |
| Millennium Management LLC | 40,721 | $187.0K | 0.00% | +7,432+22.3% | Added |
| AE Wealth Management LLC | 40,457 | $186.0K | 0.00% | +40,457 | New |
| Susquehanna International Group, LLP | 35,850 | $165.0K | 0.00% | −4,815−11.8% | Reduced |
| State Street Corp | 31,648 | $146.0K | 0.00% | 00.0% | Unchanged |
| United Asset Strategies, Inc. | 27,100 | $125.0K | 0.02% | 00.0% | Unchanged |
| Northern Trust Corp | 26,613 | $123.0K | 0.00% | −2,588−8.9% | Reduced |
| Blair William & Co | 23,840 | $110.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna Fundamental Investments, LLC | 23,800 | $109.0K | 0.00% | +23,800 | New |
| Bank of America Corp | 19,427 | $89.0K | 0.00% | +19,250+10,875.7% | Added |
| Apollon Wealth Management, LLC | 15,000 | $69.0K | 0.01% | +15,000 | New |
| Two Sigma Advisers, LP | 12,000 | $55.0K | 0.00% | +12,000 | New |
| Two Sigma Investments, LP | 10,855 | $50.0K | 0.00% | +10,855 | New |
| Russell Investments Group, Ltd. | 6,000 | $27.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,486 | $20.0K | 0.00% | +4,427+7,503.4% | Added |
| Morgan Stanley | 4,024 | $19.0K | 0.00% | −18,411−82.1% | Reduced |
| Royal Bank of Canada | 251 | $1.00K | 0.00% | −194−43.6% | Reduced |
| Wells Fargo & Company | 192 | $1.00K | 0.00% | −3−1.5% | Reduced |
| JPMorgan Chase & Co | 8 | $0 | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 50 | $0 | 0.00% | 00.0% | Unchanged |
| O'Shaughnessy Asset Management, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| IMA Wealth, Inc. | 17 | $0 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 6 | $0 | 0.00% | −94−94.0% | Reduced |
| Cutler Group LP | 117 | $0 | 0.00% | 00.0% | Unchanged |
| JNBA Financial Advisors | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 85 | $0 | 0.00% | +1+1.2% | Added |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −135,190−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −49,269−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −44,666−100.0% | Sold out |
| HN Saltoro Capital, LP | 0 | $0 | 0.00% | −11,853−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,119−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −67−100.0% | Sold out |